Get started
Author

Delphine Gueguen

Observed names: Gueguen, Delphine, gueguen, delphine
ORCID: 0000-0002-6813-0579
Observed ORCID: 0000-0002-6813-0579
OpenAlex ID: A5016033655
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
2022 · Dermot O’Toole, Pamela L. Kunz, et al. · Advances in Therapy · 17
PDF
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors
2023 · Clarisse Dromain, Marianne Pavel, et al. · Future Oncology · 7
The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors
2023 · Marianne Pavel, Clarisse Dromain, et al. · Future Oncology · 6
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel
2023 · Vincent Hautefeuille, Thomas Walter, et al. · European Journal of Endocrinology · 4
PDF
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey
2023 · Jorge Hernando, Teodora Kolarova, et al. · Journal of Neuroendocrinology · 4
PDF
Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database
2023 · Marine Perrier, Charbel Mouawad, et al. · Clinics and Research in Hepatology and Gastroenterology · 2
PDF
A Deep Dive into the RAISE Project Methodology
2025 · Marianne Pavel, Clarisse Dromain, et al. · Video Journal of Biomedicine
PDF
Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
2024 · Dermot O’Toole, Pamela L. Kunz, et al. · Advances in Therapy
PDF
Author response for "Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: results from the international HomeLAN survey"
2023 · Jorge Hernando, Teodora Kolarova, et al. · Publons reviews and discussion
Author response for "Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: results from the international HomeLAN survey"
2023 · Jorge Hernando, Teodora Kolarova, et al. · Publons reviews and discussion
Works count: 12
Citation count: 40
H-index: 4
I10-index: 1
Year
Topic
Type